BioPharma Dive - Latest News

BridgeBio oncology spinout to go public in blank-check merger

The deal comes amid an uptick in so-called SPAC deals, which had fallen out of favor due to poor returns and increased federal oversight.

Feb 28, 2025 - 17:51
 0
BridgeBio oncology spinout to go public in blank-check merger

The deal comes amid an uptick in so-called SPAC deals, which had fallen out of favor due to poor returns and increased federal oversight.

Read More

Tags:

Previous Article

Four Seasons Private Jet to host trip inspired by ‘The White Lotus’

Next Article

Is Sustainable Fashion Losing Its Most Powerful Ally?

Related Posts

Neumora bids farewell to R&D head; Biohaven’s ‘one step forward, one step back’ data

Neumora bids farewell to R&D head; Biohaven’s ‘one step...

Mar 4, 2025  0

Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division

Ferring gene therapy sales grow; ASH calls for restorat...

Apr 9, 2025  0

Mallinckrodt, Endo to combine in $7B deal

Mallinckrodt, Endo to combine in $7B deal

Mar 13, 2025  0